Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Regulatory Policy, Analysis, & Guidance

Reports

Displaying 1 - 10 of 69. 10 per page. Page 1.

Advanced Search
ASPE Data Point

Trends in In-Person and Telehealth-Involved Controlled Medication Initiations Among Adults with Private Insurance

Since March 2020, HHS and DEA have allowed health care practitioners to initiate controlled medications via a telehealth visit without first conducting an in-person medical evaluation, representing a substantial change in how these medications, and the conditions they are used to treat, can be managed.
ASPE Issue Brief

Federal Alignment with Research-Based Practices on School-Age Development and Well-Being

Childhood development experts recommend specific practices for afterschool and youth development programs to promote well-being and healthy development, including positive relationships; rich learning experiences and knowledge development; environments filled with safety and belonging; the development of skills, habits, and mindsets; and integrated support systems.
Report

Guidance on Proper Consideration of Small Entities in Rulemakings of the U.S. Department of Health and Human Services

This guidance, originally published in 2003, contains the following introduction:
ASPE Data Point

HHS Standard Values for Regulatory Analysis

The U.S. Department of Health and Human Services (HHS) analyzes the benefits, costs, and other impacts of significant proposed and final rulemakings, consistent with the requirements of several executive orders and statutes. HHS develops these analyses according to technical guidance published by the U.S.
Report

Updated Medicare FFS Telehealth Trends by Beneficiary Characteristics, Visit Specialty and State, 2019-2021

This research report updates prior reports on Medicare FFS telehealth trends during the COVID-19 public health emergency with data through end of 2021, by beneficiary characteristics, visit specialty and geography including by state. Medicare telehealth flexibilities during the COVID-19 pandemic continued to encourage use of telehealth among Medicare beneficiaries in 2021.
ASPE Issue Brief

FDA User Fees: Examining Changes in Medical Product Development and Economic Benefits

This issue brief provides a primer on FDA user fees, presents findings of how user fees affect the cost of medical product development, and summarizes the research literature on user fees, most notably in expediting medical product development and approval.
Report

Addressing Uncertainty in Regulatory Impact Analysis

In 2016, the U.S. Department of Health and Human Services finalized its Guidelines for Regulatory Impact Analysis under the leadership of its Assistant Secretary for Planning Evaluation and Analytics Team. The Guidelines discuss strategies for characterizing the uncertainty in quantified effects as well as the potential impacts of non-quantified effects.
Report

Guidelines for Regulatory Impact Analysis Supplement: Addressing International Effects

This report extends the brief discussion of addressing international effects contained in the Department of Health and Human Service Guidelines for Regulatory Impact Analysis (2016). The purpose of this supplement is to expand that discussion and provide more detailed information on conducting such assessments. Related Products:
Report

Valuing COVID-19 Mortality and Morbidity Risk Reductions in U.S. Department of Health and Human Services Regulatory Impact Analyses

This report develops an approach for valuing COVID-19 mortality and morbidity risk reductions based on the U.S. Department of Health and Human Services (HHS) Guidelines for Regulatory Impact Analysis. Valuing risk reductions associated with regulations or other policies that address the novel coronavirus disease 2019 (COVID-19) presents major challenges.
Environmental Scan

State Residential Treatment for Behavioral Health Conditions: Regulation and Policy Environmental Scan

The objective of this environmental scan is to summarize the peer-reviewed and grey literature on oversight of residential care for mental health and substance use care in the United States, excluding inpatient hospital care.